The European Society for Medical Oncology (ESMO) - a professional society representing over 50,000 members globally - welcomes the European Commissions proposal for a targeted revision of Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR).
European Society for Medical Oncology (ESMO)
NGO · Switzerland · EU Transparency Register 947929324977-41
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 311 trade unions and professional associations on this site, they rank #58 by legislative files engaged — a count of participation, not a measure of influence.
Declares membership of
- ESMO is a full member of the Union of International Cancer Control (UICC, Geneva) and the European Health Alliance on…
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Trade unions and professional associations
- Head office
- Lugano, Switzerland
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track European in PolicySpeak: request access →
Work at European Society for Medical Oncology (ESMO)? so we know who speaks for it.
Their record over time
European Society for Medical Oncology (ESMO) filed 6 positions between 10 Jun 2025 and 30 Jun 2026, across 4 of the 326 legislative files tracked here, attaching a full position paper 6 times.
What they argued
The European Society for Medical Oncology (ESMO) - a professional society representing over 45,000 members from 179 countries and territories - commends the Commission for its efforts to resolve the existential threat to oncological research in the EU, posed by the implementation of Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR).
The European Society for Medical Oncology (ESMO) - a professional society representing over 50,000 members globally - welcomes the Commissions proposal for a European Biotech Act as a timely initiative to strengthen Europes attractiveness for biomedical research and innovation, including in oncology.
The European Society for Medical Oncology (ESMO) welcomes the ambition of the European Commission to launch a proposal for a European Biotech Act. Please find the input from ESMO to the Call for Evidence attached. For further information, please contact: [email removed]
The European Society for Medical Oncology (ESMO), representing over 50,000 oncology professionals globally, welcomes the European Commissions proposal for a comprehensive EU Cardiovascular Health Plan. Cardiovascular diseases remain the leading cause of death in the EU, while cancer follows as the second leading cause, responsible for 1.3 million deaths annually in the EU.
The European Society for Medical Oncology (ESMO), representing over 50,000 members globally, welcomes the publication of the draft Implementing Act laying down the minimum metadata elements and their characteristics to be provided by health data holders for dataset descriptions for the secondary use of electronic health data under the European Health Data Space (EHDS) Regulation.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
- IDEE ECONOMICHE www.idee-economiche.it · 4 files in common
- MedTech Europe · 4 files in common
- EFPIA · 4 files in common
- European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) · 4 files in common
- Deutsche Sozialversicherung Europavertretung (DSV) · 3 files in common
Showing 5 of 69.
Is this your organization?
Everything on this page comes from European Society for Medical Oncology (ESMO)’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.